Cerenome awards Andrews options for 92,858 shares

Available on EDGAR 11/12/2026 - 08:30 AM EST Accepted by SEC EDGAR 11/12/2026 - 08:30 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Cerenome, Inc. reported that Chief Business Officer and director Ronald Asbury Andrews was awarded options to buy 92,858 common shares on November 9, 2026. The options have a $0.57 per-share exercise price and expire November 8, 2036. They vest in 48 monthly installments: 50% in 12 equal monthly installments beginning on the one-month anniversary of the grant date, and the remaining 50% in 36 equal monthly installments thereafter, subject to his continued service through each applicable vesting date.

Insider Trade Summary

Grant/Award: 92,858 shares

Grant/Award 1 txn

Insider ANDREWS RONALD ASBURY

Role Chief Business Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F1	92,858	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 92,858 options (Direct)

Holdings Before and After: Stock Option (Right to Buy), 0 to 92,858 options (Direct)

Footnotes (1)

1. F1. The options vest in forty-eight (48) monthly installments as follows: (i) fifty percent (50%) of the shares subject to the Option will vest in twelve (12) equal monthly installments during the first twelve (12) months following the Grant Date, beginning on the one-month anniversary of the Grant Date; and (ii) the remaining fifty percent (50%) of the shares subject to the Option will vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

Key Figures

Option award: 92,858 options covering common shares Exercise price: $0.57 per share Vesting schedule: 48 monthly installments +3 more

6 metrics

Option award 92,858 options covering common shares Granted November 9, 2026

Exercise price $0.57 per share Options to buy common shares

Vesting schedule 48 monthly installments Options

Initial vesting portion 50% in 12 equal monthly installments During the first 12 months following the grant date

Remaining vesting portion 50% in 36 equal monthly installments Thereafter, subject to continued service through each applicable vesting date

Expiration date November 8, 2036 Options

Key Terms

Stock Option (Right to Buy), vest, Grant Date

3 terms

Stock Option (Right to Buy) technical

"Stock Option (Right to Buy)"

vest technical

"The options vest in forty-eight (48) monthly installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Grant Date technical

"the one-month anniversary of the Grant Date"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CNSY options did Ronald Asbury Andrews receive?

On November 9, 2026, Chief Business Officer and director Ronald Asbury Andrews received an award of options covering 92,858 common shares. The exercise price is $0.57 per share, and the options expire November 8, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDREWS RONALD ASBURY

(Last) (First) (Middle)

6420 LEVIT GREEN BOULEVARD

SUITE 310

(Street)

HOUSTON TEXAS 77021

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CERENOME, INC. [ CNSY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.57	11/09/2026		A		92,858		(1)	11/08/2036	Common Stock	92,858	$0	92,858	D

Explanation of Responses:

1. The options vest in forty-eight (48) monthly installments as follows: (i) fifty percent (50%) of the shares subject to the Option will vest in twelve (12) equal monthly installments during the first twelve (12) months following the Grant Date, beginning on the one-month anniversary of the Grant Date; and (ii) the remaining fifty percent (50%) of the shares subject to the Option will vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.

	Andrew Sims, as attorney-in-fact	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)